ArticleBMC women's health2025
Cervical and breast cancer screening outcomes among Métis people in Alberta, Canada.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding cancer screening experiences of Métis people in Alberta.International journal of circumpolar health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBreast and cervical cancer rates among Métis people in Canada are higher than non-Indigenous people but the impact of cancer screening is uncertain. This study investigated breast and cervical cancer screening participation, retention, and follow-up care among age-eligible Métis people living in Alberta compared to their non-Métis counterparts from 2006 to 2022.
methodsData from the Otipemisiwak Métis Government of the Métis Nation within Alberta (MNA) Identification Registry were linked to the Alberta Breast and Cervical Cancer Screening Programs, and the Alberta Cancer Registry for the years 2006 to 2022. Relative and absolute differences in rates, percentages, and means/medians were calculated between Métis and non-Métis people, including age-eligible females, people with a cervix, and people who have taken gender-affirming hormones for five or more years. Trends were assessed using suitable Joinpoint models.
resultsMétis and non-Métis people had similar breast and cervical cancer screening participation and retention rates. However, the time between abnormal cancer screening results and follow-up tests was longer for Métis people compared to non-Métis people. Métis people had higher proportions of abnormal cytology test results, and more were diagnosed with advanced-stage cervical cancer (p = 0.06) than non-Métis people. There were no differences in breast cancer stage at diagnosis.
conclusionOngoing collaboration between the MNA and Screening Programs will build on evidence from the current study to support cancer screening programs and services for all Métis people in Alberta.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.